Citation

Giordanetto F, Wållberg A, Knerr L, Selmi N, Ullah V, Thorstensson F, Lindelöf Å, Karlsson S, Nikitidis G, Llinas A, Wang QD, Lindqvist A, Högberg G, Lindhardt E, Åstrand A, Duker G.: Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor. Bioorg Med Chem Lett, Volume 23 (1), 2013

Authors

Åstrand A, Duker G., Giordanetto F, Högberg G, Karlsson S, Knerr L, Lindelöf Å, Lindhardt E, Lindqvist A, Llinas A, Nikitidis G, Selmi N, Thorstensson F, Ullah V, Wållberg A, Wang QD

Journal

Bioorg Med Chem Lett

Year

2013

DOI

10.1016/j.bmcl.2012.10.140

PubMed

23200256

Machine-readable

REST APIRDF